These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 34923423)
1. BACH1 as a potential target for immunotherapy in glioblastomas. Yuan F; Cong Z; Cai X; Zhu J; Yuan L; Wang Y; Tang C; Ma C Int Immunopharmacol; 2022 Feb; 103():108451. PubMed ID: 34923423 [TBL] [Abstract][Full Text] [Related]
2. Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM. Zhao S; Ni K; Xie J; Cheng C; Zhao N; Liu J; Ji W; Wang Q; Zhang P; Liu Y J Neurooncol; 2024 Oct; 170(1):101-117. PubMed ID: 39143438 [TBL] [Abstract][Full Text] [Related]
3. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
4. The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma. Giordano C; Marrone L; Romano S; Della Pepa GM; Donzelli CM; Tufano M; Capasso M; Lasorsa VA; Quintavalle C; Guerri G; Martucci M; Auricchio A; Gessi M; Sala E; Olivi A; Romano MF; Gaudino S Cancer Res Commun; 2024 May; 4(5):1296-1306. PubMed ID: 38651817 [TBL] [Abstract][Full Text] [Related]
5. The N Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G Front Immunol; 2021; 12():653711. PubMed ID: 34354698 [TBL] [Abstract][Full Text] [Related]
6. MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas. Wang QW; Sun LH; Zhang Y; Wang Z; Zhao Z; Wang ZL; Wang KY; Li GZ; Xu JB; Ren CY; Ma WP; Wang HJ; Li SW; Zhu YJ; Jiang T; Bao ZS J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34667077 [TBL] [Abstract][Full Text] [Related]
7. BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition. Han W; Zhang Y; Niu C; Guo J; Li J; Wei X; Jia M; Zhi X; Yao L; Meng D Cancer Lett; 2019 Mar; 445():45-56. PubMed ID: 30654010 [TBL] [Abstract][Full Text] [Related]
8. COL8A1 is a potential prognostic biomarker associated with migration, proliferation, and tumor microenvironment in glioma. Liu M; Liang W; Su Y; Wen Y; Qi J; Wang L; Su S; Zhao J; Shan J; Wang J Exp Cell Res; 2024 Jun; 439(1):114076. PubMed ID: 38719174 [TBL] [Abstract][Full Text] [Related]
9. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Zhou W; Ke SQ; Huang Z; Flavahan W; Fang X; Paul J; Wu L; Sloan AE; McLendon RE; Li X; Rich JN; Bao S Nat Cell Biol; 2015 Feb; 17(2):170-82. PubMed ID: 25580734 [TBL] [Abstract][Full Text] [Related]
10. IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy. Ye F; Wang L; Li Y; Dong C; Zhou L; Xu J Front Immunol; 2023; 14():1338244. PubMed ID: 38250074 [TBL] [Abstract][Full Text] [Related]
11. Identification of a unique tumor cell subset employing myeloid transcriptional circuits to create an immunomodulatory microenvironment in glioblastoma. Yang K; Shi Y; Luo M; Mao M; Zhang X; Chen C; Liu Y; He Z; Liu Q; Wang W; Luo C; Yin W; Wang C; Niu Q; Zeng H; Bian XW; Ping YF Oncoimmunology; 2022; 11(1):2030020. PubMed ID: 35096487 [TBL] [Abstract][Full Text] [Related]
12. Correlation of Tim-3 expression with chemokine levels for predicting the prognosis of patients with glioblastoma. Zhu Z; Zhang X; Yu Z; Zhou Y; Zhu S; Zhang YH; Lin XP; Mou Y; Zhang J J Neuroimmunol; 2021 Jun; 355():577575. PubMed ID: 33901809 [TBL] [Abstract][Full Text] [Related]
14. TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling. Peng P; Zhu H; Liu D; Chen Z; Zhang X; Guo Z; Dong M; Wan L; Zhang P; Liu G; Zhang S; Dong F; Hu F; Cheng F; Huang S; Guo D; Zhang B; Yu X; Wan F Theranostics; 2022; 12(9):4221-4236. PubMed ID: 35673564 [No Abstract] [Full Text] [Related]
15. Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients. Xin H; Chen Y; Niu H; Li X; Gai X; Cui G Dig Dis Sci; 2024 Jun; 69(6):2055-2073. PubMed ID: 38573378 [TBL] [Abstract][Full Text] [Related]
16. LINC00665 interacts with BACH1 to activate Wnt1 and mediates the M2 polarization of tumor-associated macrophages in GC. Yang B; Su K; Sha G; Bai Q; Sun G; Chen H; Xie H; Jiang X Mol Immunol; 2022 Jun; 146():1-8. PubMed ID: 35395473 [TBL] [Abstract][Full Text] [Related]
17. Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts. Leiss L; Mutlu E; Øyan A; Yan T; Tsinkalovsky O; Sleire L; Petersen K; Rahman MA; Johannessen M; Mitra SS; Jacobsen HK; Talasila KM; Miletic H; Jonassen I; Li X; Brons NH; Kalland KH; Wang J; Enger PØ BMC Cancer; 2017 Feb; 17(1):108. PubMed ID: 28173797 [TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing reveals intra-tumoral heterogeneity of glioblastoma and a pro-tumor subset of tumor-associated macrophages characterized by EZH2 overexpression. Chen X; Chen Y; Chen X; Wei P; Lin Y; Wu Z; Lin Z; Kang D; Ding C Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166534. PubMed ID: 36057370 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Molecular Analyses of an M2-Like Tumor-Associated Macrophage for Predicting the Prognosis and Immunotherapy in Breast Cancer. Chang K; Yue Q; Jin L; Fan P; Liu Y; Cao F; Zhang Y J Immunother; 2024 Jul-Aug 01; 47(6):205-215. PubMed ID: 38686904 [TBL] [Abstract][Full Text] [Related]
20. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients. Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q Front Immunol; 2023; 14():1263329. PubMed ID: 37727789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]